125 related articles for article (PubMed ID: 36324096)
1. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
Nilson EAF; Khandpur N; da Silva Gomes F
BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
[TBL] [Abstract][Full Text] [Related]
2. Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease.
Wang Q; Afshin A; Yakoob MY; Singh GM; Rehm CD; Khatibzadeh S; Micha R; Shi P; Mozaffarian D;
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26790695
[TBL] [Abstract][Full Text] [Related]
3. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
[TBL] [Abstract][Full Text] [Related]
4. Projecting cardiovascular deaths averted due to trans fat policies in the Eurasian Economic Union.
Rieger M; Rippin HL; Pinedo A; Whiting S; Farrand C; Wickramasinghe K; Breda JJ
Public Health Nutr; 2023 Dec; 26(S1):s41-s50. PubMed ID: 36184895
[TBL] [Abstract][Full Text] [Related]
5. Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis.
Nilson EAF; Pearson-Stuttard J; Collins B; Guzman-Castillo M; Capewell S; O'Flaherty M; Jaime PC; Kypridemos C
BMC Med; 2021 Sep; 19(1):225. PubMed ID: 34583695
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Complexities of Eliminating Trans Fatty Acids: The Case of the Trans Fatty Acid Ban in Thailand.
Samsiripong W; Phulkerd S; Pattaravanich U; Kanchanachitra M
Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807928
[TBL] [Abstract][Full Text] [Related]
7. The estimated burden of ultra-processed foods on cardiovascular disease outcomes in Brazil: A modeling study.
Nilson EAF; Ferrari G; Louzada MLDC; Levy RB; Monteiro CA; Rezende LFM
Front Nutr; 2022; 9():1043620. PubMed ID: 36466395
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Policies to Reduce
Downs SM; Bloem MZ; Zheng M; Catterall E; Thomas B; Veerman L; Wu JH
Curr Dev Nutr; 2017 Dec; 1(12):. PubMed ID: 29955689
[No Abstract] [Full Text] [Related]
9. Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis.
Marklund M; Aminde LN; Wanjau MN; Huang L; Awuor C; Steele L; Cobb LK; Veerman JL; Wu JH
BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37848268
[TBL] [Abstract][Full Text] [Related]
10. Proportions of trans fatty acids in erythrocytes of Canadian adults before the prohibition of partially hydrogenated oils in foods: results from the Canadian Health Measures Survey 2012-2015.
Demonty I; Nguyen L; MacFarlane AJ; Rudkowska I; Zoka R; Hopperton KE
Am J Clin Nutr; 2024 Jun; 119(6):1485-1494. PubMed ID: 38583806
[TBL] [Abstract][Full Text] [Related]
11. Trans fatty acids - A risk factor for cardiovascular disease.
Iqbal MP
Pak J Med Sci; 2014 Jan; 30(1):194-7. PubMed ID: 24639860
[TBL] [Abstract][Full Text] [Related]
12. Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil.
Nilson EAF; Metlzer AB; Labonté ME; Jaime PC
PLoS One; 2020; 15(7):e0235514. PubMed ID: 32645031
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the
Chavasit V; Photi J; Kriengsinyos W; Ditmetharoj M; Preecha S; Tontisirin K
Curr Dev Nutr; 2019 Jun; 3(6):nzz045. PubMed ID: 31139767
[TBL] [Abstract][Full Text] [Related]
14. Disability and costs of IHD attributable to the consumption of trans-fatty acids in Brazil.
Parajára MDC; Fogal Vegi AS; Machado ÍE; Menezes MC; Verly-Jr E; Meireles AL
Public Health Nutr; 2024 May; 27(1):e132. PubMed ID: 38726481
[TBL] [Abstract][Full Text] [Related]
15. Understanding the complexities of prevalence of trans fat and its control in food supply in Pakistan.
Tarar OM; Ahmed KM; Nishtar NA; Achakzai ABK; Gulzar Y; Delles C; Al-Jawaldeh A
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1338-1346. PubMed ID: 32687252
[TBL] [Abstract][Full Text] [Related]
16. Estimating the dietary and health impact of implementing front-of-pack nutrition labeling in Canada: A macrosimulation modeling study.
Flexner N; Ng AP; Ahmed M; Khandpur N; Acton RB; Lee JJ; L'Abbe MR
Front Nutr; 2023; 10():1098231. PubMed ID: 37006927
[TBL] [Abstract][Full Text] [Related]
17. Plasma
Vesper HW; Caudill SP; Kuiper HC; Yang Q; Ahluwalia N; Lacher DA; Pirkle JL
Am J Clin Nutr; 2017 May; 105(5):1063-1069. PubMed ID: 28381474
[No Abstract] [Full Text] [Related]
18. Estimating Canadian sodium intakes and the health impact of meeting national and WHO recommended sodium intake levels: A macrosimulation modelling study.
Flexner N; Christoforou AK; Bernstein JT; Ng AP; Yang Y; Fernandes Nilson EA; Labonté MÈ; L'Abbe MR
PLoS One; 2023; 18(5):e0284733. PubMed ID: 37163471
[TBL] [Abstract][Full Text] [Related]
19. Ruminant and industrially produced trans fatty acids: health aspects.
Stender S; Astrup A; Dyerberg J
Food Nutr Res; 2008; 52():. PubMed ID: 19109659
[TBL] [Abstract][Full Text] [Related]
20. On account of trans fatty acids and cardiovascular disease risk - There is still need to upgrade the knowledge and educate consumers.
Niforou A; Magriplis E; Klinaki E; Niforou K; Naska A
Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1811-1818. PubMed ID: 35753860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
